IFNK
Interferon kappa
Also known as: IFNK_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9P0W0
- Gene
- IFNK
- Ensembl
- ENSG00000147896
- Chromosome
- 9
- Canonical length
- 207 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a member of the type I interferon family. Type I interferons are a group of related glycoproteins that play an important role in host defenses against viral infections. This protein is expressed in keratinocytes and the gene is found on chromosome 9, adjacent to the type I interferon cluster. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
207 residues, UniProt reviewed canonical sequence.
>Q9P0W0|IFNK
1 MSTKPDMIQK CLWLEILMGI FIAGTLSLDC NLLNVHLRRV TWQNLRHLSS MSNSFPVECL
61 RENIAFELPQ EFLQYTQPMK RDIKKAFYEM SLQAFNIFSQ HTFKYWKERH LKQIQIGLDQ
121 QAEYLNQCLE EDKNENEDMK EMKENEMKPS EARVPQLSSL ELRRYFHRID NFLKEKKYSD
181 CAWEIVRVEI RRCLYYFYKF TALFRRKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IFNK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 0 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
- appendix: 0 nTPM
- basal ganglia: 0 nTPM
- blood vessel: 0 nTPM
Single-cell type
- epicardial cells: 4.5 nCPM
- cardiomyocytes: 3.2 nCPM
- müller glia: 0.7 nCPM
- vascular smooth muscle cells: 0.7 nCPM
- macrophages: 0.6 nCPM
- neutrophils: 0.6 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 13 nTPM
- medulla oblongata: 12 nTPM
- basal ganglia: 11 nTPM
- thalamus: 11 nTPM
- choroid plexus: 10 nTPM
- midbrain: 9.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.9
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.34
- DepMap mean gene effect
- 0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- B cell activation involved in immune response
- cellular response to virus
- cytokine-mediated signaling pathway
- defense response to virus
- humoral immune response
- natural killer cell activation
- natural killer cell activation involved in immune response
- negative regulation of cell population proliferation
- positive regulation of innate immune response
- regulation of DNA-templated transcription
- response to exogenous dsRNA
- response to virus
- T cell activation involved in immune response
- type I interferon-mediated signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IFNK as an antibody target. Whether an autoantibody or antibody against IFNK could matter depends on whether native IFNK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IFNK is annotated as secreted, so native IFNK circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IFNK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...